Beyond Refraction: Using Axial Length Data to Manage Myopia Progression

Axial length is one of the more useful measurements we have when managing myopia in children, particularly when you’re trying to understand progression rather than confirm it.

In isolation, a single reading doesn’t tell you much. Where it becomes clinically valuable is when you start placing that measurement in context, against expected growth for a child’s age, and then tracking how it changes over time.

Because what you’re really trying to establish is not just whether a child is myopic, but how likely they are to become myopic, and how quickly that process is likely to occur.

 

Let’s put this into context:

Imagine this: a six-year-old patient with no complaints – Cara

Cara’s vision is clear, visual acuity is normal, and her refraction sits around plano in both eyes.

There’s nothing here that would usually prompt concern.

Her lifestyle looks reasonable. She spends time outdoors, her near work is not excessive, and family history may be present, but is not particularly strong.

On paper, this is a low-risk patient.

But then you factor in axial length data. This is exactly what Dr Phillipp Hessler, CEO of Optik Hessler, did. 

When measured and compared against age-based normative data, the patient’s axial length sits outside the expected range. Not dramatically so, but enough to raise concern about how her eyes are developing.

In cases like the above, children with this exact profile – normal refraction, normal acuity, limited apparent risk factors – were still predicted to progress to high myopia, in the region of -6.00 D, based on axial length and associated clinical findings.

As clinicians, we’re no longer deciding whether a child is myopic. Instead, we need to assess whether they are likely to become myopic, and whether that process has already started. 

 

Managing myopia risk in children – what happens next

What the above highlights is that risk isn’t always obvious from history alone. 

Taken individually, Cara’s risk factors wouldn’t necessarily warrant early intervention, but when the axial length falls outside expected growth, it changes how we interpret these factors. 

In Cara’s case, looking more closely at how her eyes were working together and focusing up close highlighted additional risk, even though her day-to-day habits didn’t raise concern.

This is where axial length becomes particularly useful. It gives you a reference point that isn’t dependent on subjective responses or short-term variability, and it allows you to identify children who may otherwise be missed if you are relying on refraction and history alone.

It also changes the timing of the conversation. Rather than waiting for myopia to present, you’re identifying children who are already on that trajectory.

As you can see from the results from Dr Hessler’s OCULUS Myopia Master, the highest risk factors sit around accommodation and binocular function.

In Cara’s case, there’s a clear lag in accommodation, alongside imbalances in how the eyes are working together at near. That combination is associated with increased myopia progression risk and helps explain why she was flagged despite otherwise unremarkable refraction and lifestyle factors.

 

Making the right treatment decisions

Once you’ve identified progression risk, the next step isn’t simply whether to intervene, but how that intervention fits the patient in front of you.

We’re not looking at correction here, we’re looking at control (we can’t work miracles and reverse axial elongation, after all!). 

In practice, that decision rarely comes down to a single data point. You’re weighing growth rate, position relative to expected data, binocular findings, and the broader clinical picture.

Treatment choice reflects that.

In documented cases of progressive myopia, spectacle-based options have been selected over contact lenses not just for their effect on progression, but to maintain stability in vergence and accommodative relationships where these are already borderline.

You’re not treating axial length in isolation; you’re working with the whole visual system, and the best option is the one that fits that system most appropriately.

 

What does this mean in practice?

In Cara’s case, what changed wasn’t the presence of myopia, but how her risk was interpreted. 

Refraction and lifestyle alone wouldn’t have raised much concern. It was the combination of axial length and how her visual system was performing at near that changed how Dr Hessler looked at things. 

That allowed for earlier intervention, based on risk and progression rather than waiting for a clear refractive change.

The treatment plan reflects that. Options such as contact lenses and atropine were considered, but not all were appropriate given her accommodative profile. Instead, the approach focused on reducing near demand and supporting how her eyes were working together, alongside ongoing monitoring.

That’s typically how this plays out in practice.

 

Where the Myopia Master fits into all of this

If you’re already working with axial length, none of this is new. The challenge is making it practical in a busy clinic.

That’s where an instrument like the Myopia Master makes a big difference.

Rather than pulling data from multiple devices and trying to piece it together, you’ve got axial length, refraction and keratometry in one place, with everything plotted against age-based growth data automatically. It saves time, but more importantly, it gives you context straight away.

So instead of looking at disparate data and having to interpret it manually, you can see immediately whether that patient is tracking as expected or starting to move outside it.

It becomes even more useful over time, as you’re not comparing notes between visits or relying on memory; you can see trends clearly, which makes it much easier to decide whether things are stabilising or if you need to step in.

It also helps you communicate what’s happening better to parents. 

When parents can see how their child’s eye growth compares to expected patterns, the conversation becomes much more straightforward. You’re not just describing risk, you’re showing it.

The Myopia Master helps you visually demonstrate the difference lenses make in myopia management.

Ultimately, it doesn’t change the fundamentals of how you manage myopia.

What it does is make it easier to measure, interpret and communicate those decisions earlier, and with more consistency across visits.

To summarise, the Myopia Master:

• Combines axial length, refraction and keratometry in a single measurement, reducing the need for multiple devices 
• Provides axial length measurements independent of accommodation, supporting more reliable progression tracking 
• Plots results against age-based growth curves for immediate clinical context 
• Highlights deviation from expected eye growth, helping identify at-risk patients earlier 
• Tracks changes over time, making progression easier to monitor across visits 
• Supports more confident clinical decision-making with objective, repeatable data 
• Incorporates risk factor analysis alongside measurement data for a more complete assessment 
• Generates clear visual outputs that make patient and parent communication more straightforward 
• Produces reports that can be shared digitally or in print to support ongoing engagement 
• Fits into a standard appointment with fast, non-contact measurements

If you’re looking for an instrument that makes integrating axial length data into your myopia management process easier, we’d be happy to talk you through things. 

Whether you want to see how it functions in your practice or you just want to know a little more about what it can do, reach out today. 

[Improve your myopia management process]